Your browser doesn't support javascript.
loading
Sofosbuvir + velpatasvir + voxilaprevir for the treatment of hepatitis C infection.
Cory, Theodore J; Mu, Ying; Gong, Yuqing; Kodidela, Sunitha; Kumar, Santosh.
Affiliation
  • Cory TJ; a Department of Clinical Pharmacy and Translational Science , University of Tennessee Health Science Center College of Pharmacy , Memphis , TN , USA.
  • Mu Y; a Department of Clinical Pharmacy and Translational Science , University of Tennessee Health Science Center College of Pharmacy , Memphis , TN , USA.
  • Gong Y; b Department of Pharmaceutical Sciences , University of Tennessee Health Science Center College of Pharmacy , Memphis , TN , USA.
  • Kodidela S; b Department of Pharmaceutical Sciences , University of Tennessee Health Science Center College of Pharmacy , Memphis , TN , USA.
  • Kumar S; b Department of Pharmaceutical Sciences , University of Tennessee Health Science Center College of Pharmacy , Memphis , TN , USA.
Expert Opin Pharmacother ; 19(7): 749-757, 2018 May.
Article in En | MEDLINE | ID: mdl-29634360

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Sulfonamides / Carbamates / Hepatitis C, Chronic / Macrocyclic Compounds / Drug Therapy, Combination / Sofosbuvir / Heterocyclic Compounds, 4 or More Rings Limits: Humans Language: En Journal: Expert Opin Pharmacother Journal subject: FARMACOLOGIA Year: 2018 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Sulfonamides / Carbamates / Hepatitis C, Chronic / Macrocyclic Compounds / Drug Therapy, Combination / Sofosbuvir / Heterocyclic Compounds, 4 or More Rings Limits: Humans Language: En Journal: Expert Opin Pharmacother Journal subject: FARMACOLOGIA Year: 2018 Document type: Article Affiliation country: Estados Unidos